Keyphrases
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Androgen Deprivation Therapy
100%
Clinical Characterization
100%
Molecular Subtypes
100%
Genomic Characterization
100%
Lung
40%
Prostate Cancer
40%
Metastasis
40%
Prostate-specific Antigen
40%
Failure-free Survival
40%
Median Overall Survival
40%
Prostate-specific Antigen Response
40%
Durable Response
20%
Medical Records
20%
Germ Cells
20%
Cancer Biology
20%
Prostate Cancer Patients
20%
Clinical Endpoints
20%
Tropics
20%
DNA Repair
20%
Molecular Alterations
20%
Retrospective Review
20%
Clinical Grade
20%
Homologous Recombination Deficiency
20%
Historical Data
20%
Mismatch Repair
20%
Nave
20%
Baseline Characteristics
20%
Large Cohort
20%
Survival Rate
20%
First-degree Relatives
20%
Tumor Tissue
20%
Small Sample Size
20%
Therapy Initiation
20%
Progression-free Survival
20%
DNA Repair Genes
20%
Gene Alteration
20%
Single Institution Study
20%
Genetic Results
20%
Pulmonary Involvement
20%
Molecular Drivers
20%
Second-degree Relatives
20%
Next-generation DNA Sequencing
20%
Exceptional Responders
20%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
100%
Genomics
100%
DNA Repair
50%
Overall Survival
50%
Failure Free Survival
50%
Germline
25%
Homologous Recombination
25%
Prevalence
25%
Gene Mutation
25%
DNA Sequence
25%
Sample Size
25%
Medical Record
25%
Survival Rate
25%
DNA Mismatch Repair
25%
Progression Free Survival
25%
Germ Cell
25%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Deprivation Therapy
71%
Prostate Specific Antigen
57%
Lung
28%
Metastatic Carcinoma
28%
DNA Repair
28%
Overall Survival
28%
Failure Free Survival
28%
Antigen Response
28%
Neoplasm
14%
Cancer Pathobiology
14%
Somatics
14%
Prevalence
14%
Homologous Recombination
14%
Medical Record
14%
Progression Free Survival
14%
Survival Rate
14%
DNA Mismatch Repair
14%
Gene Mutation
14%
DNA Sequence
14%
Clinical Endpoint
14%
Germ Cell
14%
Immunology and Microbiology
Prostate
100%
Prostate Specific Antigen
80%
Antigen Response
40%
Overall Survival
40%
Failure Free Survival
40%
DNA Repair
40%
Mismatch Repair
20%
Prevalence
20%
DNA Sequence
20%
Medical Record
20%
Gene Mutation
20%
Survival Rate
20%
Sample Size
20%
Progression Free Survival
20%
Homologous Recombination
20%
Germ Cell
20%